Sprint Bioscience AB Market Cap

Sprint Bioscience AB has a market cap or net worth of 198.90 million as of March 6, 2026. Its market cap has increased by 75.41% in one year.

Market Cap

198.90M

Enterprise Value

72.19M

Revenue

167.17M

Ranking

n/a

PE Ratio

1.92

Stock Price

1.89

Market Cap Chart

Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 198.90M, an increase of 218.26%. That is a compound annual growth rate of 10.75%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	198.90M	28.23%
Dec 30, 2025	155.11M	40.43%
Dec 30, 2024	110.46M	-8.82%
Dec 29, 2023	121.14M	449.78%
Dec 30, 2022	22.03M	-88.47%
Dec 30, 2021	191.05M	17.26%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Isofol Medical AB	194.67M
Initiator Pharma	204.67M
AlzeCure Pharma AB	217.76M
Xintela AB	223.93M
Intervacc AB	229.71M
Magle Chemoswed Holding AB	161.07M
Simris Group AB (PUBL)	157.93M
Mendus AB	258.28M

Market Cap Rankings